Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy (DRV900100QD)

This study has been completed.

Sponsor:

Information provided by:

Germans Trias i Pujol Hospital

ClinicalTrials.gov Identifier:

NCT00611039

First received: January 28, 2008

Last updated: October 5, 2009

Last verified: October 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	July 2009
Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)

No publications provided by Germans Trias i Pujol Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Moltó J, Valle M, Santos JR, Mothe B, Miranda C, Cedeño S, Negredo E, Yritia M, Videla S, Barbanoj MJ, Clotet B. Treatment simplification to once daily darunavir/ritonavir guided by the darunavir inhibitory quotient in heavily pretreated HIV-infected patients. Antivir Ther. 2010;15(2):219-25.

To Top